FDA recommends we conduct a randomized, double-blinded, placebo-controlled Phase II for Intravenous (IV) and Inhaled Ampion to allow consideration of...
Globalstar, Inc. (NYSE American: GSAT) today announced financial and operating results for the fourth quarter and year ended December 31,...
Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355-Advanced arimoclomol in 4 rare disease indications; announced global brand name of arimoclomol (MIPLYFFATM1);...
TipRanksBillionaire Steven Cohen Picks Up These 3 “Strong Buy” StocksLast 7 days, the NASDAQ slipped beneath 13,200, earning the net...
Steve Marin runs Spark PPC, a advertising consulting agency based mostly in New York Town, he focuses on small to...
BloombergGreatest Bitcoin Fund Sinks to Document Lower price as Mania Cools(Bloomberg) -- The world’s biggest Bitcoin fund is providing off...
Strategic Education, Inc. (Strategic Education) (NASDAQ: STRA) today announced financial results for the period ended December 31, 2020."We are encouraged...
- UPLIFT, a single-arm registration strategy evaluating upifitamab rilsodotin (UpRi) in platinum-resistant ovarian cancer, on track to begin in Q1...
VXA-CoV2-1 oral COVID-19 vaccine candidate targeting both the S and N proteins is planned to advance to Phase 2 testing...
Company demonstrates resilience despite COVID-19 challenges: Financial situation secure and development programs progressingConference call begins today at 4:30 p.m. (ET)BASKING...
Lund, Sweden, February 26, 2021 – Terranet AB (Terranet/the Business), (Nasdaq: TERRNT-B.ST), developers of sophisticated driver-assist methods and the creators...
2021 Vaccine Manufacturing: Raises lower end of global manufacturing plan for 2021 from 600 million doses to 700 million doses;...
– 2020 Highlights Include: Enrollment Completion of Pivotal PHYOX™2 Trial of Nedosiran for Primary Hyperoxaluria; Positive RG6346 Phase 1 Data...
- Initiated the Phase 2b SOOTHE clinical trial in refractory chronic cough; topline results expected Q4 2021 with an interim...
Passenger traffic continues to reflect travel disruptions worldwide due to the COVID-19 pandemicMEXICO CITY, Feb. 24, 2020 /PRNewswire/ -- Grupo...
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
2020 Net Revenues of $83.1 Million Increased 19% over 2019Fourth Quarter Net Revenues of $24.7 Million or $80 Per BottleNew...
SAN FRANCISCO, Feb. 25, 2021 /PRNewswire/ -- Marin Software Incorporated (NASDAQ: MRIN), a leading provider of digital marketing software for...
